118 related articles for article (PubMed ID: 6530623)
1. Thromboxane-B2 generation during ex-vivo platelet aggregation.
De Caterina R; Giannessi D; Gazzetti P; Bernini W
J Nucl Med Allied Sci; 1984; 28(3):185-96. PubMed ID: 6530623
[No Abstract] [Full Text] [Related]
2. Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Adv Prostaglandin Thromboxane Res; 1980; 6():187-91. PubMed ID: 7386257
[No Abstract] [Full Text] [Related]
3. Methodological assessment and applications of a radioimmunoassay for thromboxane (TxB2) to measurement of TxB2 release by platelets.
Giannessi D; De Caterina R; Gazzetti P; Bernini W; Masini S; Zucchelli GC
J Nucl Med Allied Sci; 1982; 26(1):25-33. PubMed ID: 7108634
[No Abstract] [Full Text] [Related]
4. Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.
Nuotto E; Gordin A; Paasonen MK; Metsä-Ketelä T; Lamminsivu U
Eur J Clin Pharmacol; 1983; 25(3):313-7. PubMed ID: 6628518
[TBL] [Abstract][Full Text] [Related]
5. Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay.
Viinikka L; Ylikorkala O
Prostaglandins; 1980 Oct; 20(4):759-66. PubMed ID: 7465865
[No Abstract] [Full Text] [Related]
6. A radioimmunoassay for thromboxane B2.
Fitzpatrick FA; Gorman RR; Mc Guire JC; Kelly RC; Wynalda MA; Sun FF
Anal Biochem; 1977 Sep; 82(1):1-7. PubMed ID: 907115
[No Abstract] [Full Text] [Related]
7. Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Mehta J; Mehta P
Acta Med Scand Suppl; 1981; 651():111-21. PubMed ID: 6948499
[No Abstract] [Full Text] [Related]
8. Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Gensini GF; Rostagno C; Pezza A; Fanara F; Castellani S; Prisco D; Rogasi PG; Boddi M; Neri Serneri GG
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():257-62. PubMed ID: 3159209
[No Abstract] [Full Text] [Related]
9. Paradoxical effects of indomethacin and trifluoperazine on Ca2+ ionophore A23187-induced human platelet aggregation, thromboxane B2 production, and dense granule release.
Krishnamurthi S; Westwick J; Kakkar VV
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():435-40. PubMed ID: 6221559
[No Abstract] [Full Text] [Related]
10. Thromboxane B2 (TxB2) release during IgE anaphylaxis in the rabbit.
McManus LM; Shaw JO; Pinckard RN
J Immunol; 1980 Nov; 125(5):1950-4. PubMed ID: 7430618
[No Abstract] [Full Text] [Related]
11. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
Takeda H; Kashimura Y; Takeoka T; Hashimoto M; Tanabe T
Kyobu Geka; 1984 Sep; 37(10):773-7. PubMed ID: 6389949
[No Abstract] [Full Text] [Related]
12. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay for plasma thromboxane B2.
McCann DS; Tokarsky J; Sorkin RP
Clin Chem; 1981 Aug; 27(8):1417-20. PubMed ID: 7273401
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
[TBL] [Abstract][Full Text] [Related]
15. Platelet thromboxanes and serum-cholesterol.
Tremoli E; Folco G; Agradi E; Galli C
Lancet; 1979 Jan; 1(8107):107-8. PubMed ID: 84115
[No Abstract] [Full Text] [Related]
16. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Colwell JA
J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
[TBL] [Abstract][Full Text] [Related]
18. Dose- and time-dependent antiplatelet effects of aspirin.
Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
[TBL] [Abstract][Full Text] [Related]
19. Changes in thromboxane formation by platelets during and after a continuous endotoxin infusion into rabbits.
Ditter H; Matthias FR
Vasa; 1984; 13(4):327-32. PubMed ID: 6516562
[No Abstract] [Full Text] [Related]
20. Enzyme immunoassay of thromboxane B2.
Hayashi Y; Ueda N; Yokota K; Kawamura S; Ogushi F; Yamamoto Y; Yamamoto S; Nakamura K; Yamashita K; Miyazaki H; Kato K; Terao S
Biochim Biophys Acta; 1983 Feb; 750(2):322-9. PubMed ID: 6407530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
